Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


BioElectronics Corp. and Locin Industries Ltd. Bring ActiPatch(TM) to Canadian Retail Market

   Drug-free ActiPatch Product for Pain Relief and Faster Healing of Soft
                  Tissue Injuries Available Soon In Canada

    FREDERICK, Md., May 13 /PRNewswire-FirstCall/ -- BioElectronics Corp.
(Pink Sheets: BIEL), the maker of ActiPatch(TM), a drug free
anti-inflammatory patch, with an embedded battery operated microchip, which
delivers weeks of continuous pulse therapy for a few cents an hour, and
Locin Industries Limited, one of Canada's leading distributors to the
Canadian retail sector today announced the upcoming launch of the ActiPatch
brand into the Canadian retail sector. Through this partnership, national
and regional retailers and wholesalers in the grocery, drug mass
merchandise and club channels across Canada will begin stocking ActiPatch
products beginning this summer. In advance of the retail launch, Canadian
consumers can purchase the ActiPatch directly at ActiPatchPainTherapy.ca.

    "We are very pleased to partner with Locin to bring this revolutionary
product to the Canadian retail marketplace. Since receiving our Health
Canada approval, interest in our drug-free, anti-inflammatory patch
products is increasing and we are very excited that Canadian consumers will
be able to easily purchase our product by simply visiting a local
retailer," commented Andrew Whelan, president and CEO of BioElectronics
Corporation. "Our company is all about speeding recovery of injury and
reducing pain and we are very happy that Canadian consumers will soon be
able to enjoy the significant benefits of our products," explains Whelan.

    Brad Collins, Vice President of Locin Industries Ltd. adds, "Our key
strengths are our customer and vendor relationships that we have fostered
for over 30 years. We believe we will be able to leverage these strengths
in order to effectively launch this significant new product into the
Canadian market. We are very pleased to be working with BioElectronics
Corporation on this endeavor and look forward to providing our national and
regional retailers and wholesalers with what we believe will be a very
popular product with Canadian consumers."

    About BioElectronics Corporation

    BioElectronics Corporation is the maker of the ActiPatch(TM). ActiPatch
is a drug-free anti-inflammatory patch with an embedded battery operated
microchip that delivers weeks of continuous pulsed therapy for about a
dollar a day. The unique ActiPatch delivery system, using patented
technology, provides a cost-effective patient friendly method to reduce
soft tissue pain and swelling. ActiPatch is approved by Health Canada for
the relief of pain in musculoskeletal complaints. The US government's food
and drug administration (FDA) has cleared the use of the product for
reducing edema (swelling) following blepharoplasty and the European Union
has approved the product as a class two pulsed electromagnetic medical
device as have numerous other international record for agencies.
Information on ActiPatch and BioElectronics Corporation is available at the
following websites:


-- U.S. Consumer http://www.actipatchonline.com -- Podiatry: http://www.pemfpodiatry.com -- Plastic Surgery: http://www.plasticsurgery.com and http://www.makemeheal.com -- German orthopedic foot & ankle: http://www.diesfussexperten.de -- Italy and Switzerland: http://www.actipatch.it -- Canada: ActiPatchPainTherapy.ca -- BioElectronics Corp: http://www.bioelectronicscorp.com Safe Harbor Statement This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies In light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the company has no control.
Media Contact: Patricia Baker, The Big Picture Agency LLC Voice: 413-623-0950 ext. 221, email: pbaker@bigpictureagency.com Investor Relations Contact: Joe Noel, Emerging Growth Research LLP Voice: 925-922-2560, email: jnoel701@emerginggrow.com About Locin Industries Ltd. Locin Industries Ltd., headquartered in North Vancouver, British Columbia, is a full service distributor serving all national and regional retailers and wholesalers in the grocery, drug, mass merchandise and club channels in Canada. The family-owned and operated company relies heavily on its customer and vendor relationships that have been fostered over a period spanning more than 30 years to provide effective brand and category management including retail head office liaison, trade and consumer advertising, promotional development and planning, data analysis and forecasting, and national retail merchandising services. Locin has extensive experience in getting regulatory clearance and approval with Health Canada, a critical step in bringing medical devices and natural health products to the growing Canadian market. Locin has also branched into the dynamic Direct Response retail channel, creating compelling web and call center based sales solutions for unique, high quality and effective health and beauty care products. Information about Locin Industries Ltd is available at: http://www.locin.com
SOURCE BioElectronics Corp.




Back to Topback to top

Related links:
  • http://www.bioelectronicscorp.com
  • http://www.locin.com
    CONTACT:
    Patricia Baker, The Big Picture Agency LLC,
    +1-413-623-0950 ext. 221, pbaker@bigpictureagency.com; Investor
    Relations, Joe Noel, Emerging Growth Research LLP,
    +1-925-922-2560, jnoel701@emerginggrow.com